Most Important Questions of Life Science: Cancer Pathogenesis! (Download PDF)

By Renuka Miglani|Updated : September 29th, 2021

Hello Aspirants,

It will not be a new thing for you if we say that BYJU'S Exam Prep is considered as the synonym for success. For the past 5 years, At BYJU'S Exam Prep we have been promoting talented candidates of the CSIR-NET category to the path of success. BYJU'S Exam Prep has been an integral part of the preparation journey of many Aspirants.

As we all know, the CSIR-NET exam is very near and there is no time left for revision. At this point of time, you must be seeking some ready-made authentic short revision notes or some important questions to practice just before the exam. How will you react if you get all these study materials at one place? It will be beneficial for you at this time right! We at BYJU'S Exam Prep comes up with the Most Important Questions of Cancer Pathogenesis for Life Sciences to help you score good marks which have been meticulously designed by our experienced subject-matter experts.

So what are you waiting for? Scroll down the article below and start study for the CSIR NET Exam, these questions will be fruitful during last-minute revision to fetch more marks in the exams. Students can also download it as a PDF file and save it for future purposes.

Hello Aspirants,

It will not be a new thing for you if we say that BYJU'S Exam Prep is considered as the synonym for success. For the past 5 years, At BYJU'S Exam Prep we have been promoting talented candidates of the CSIR-NET category to the path of success. BYJU'S Exam Prep has been an integral part of the preparation journey of many Aspirants.

As we all know, the CSIR-NET exam is very near and there is no time left for revision. At this point of time, you must be seeking some ready-made authentic short revision notes or some important questions to practice just before the exam. How will you react if you get all these study materials at one place? It will be beneficial for you at this time right! We at BYJU'S Exam Prep comes up with the Most Important Questions of Cancer Pathogenesis for Life Sciences to help you score good marks which have been meticulously designed by our experienced subject-matter experts.

So what are you waiting for? Scroll down the article below and start study for the CSIR NET Exam, these questions will be fruitful during last-minute revision to fetch more marks in the exams. Students can also download it as a PDF file and save it for future purposes.

CANCER PATHOGENESIS - Most Important Questions! (Download PDF)

Q1. Match the following -

COLUMN A (Virus)

COLUMN B (human cancer type)

a. Papilloma

i. Burkitt’s lymphoma

b. Epstein Barr

ii. cervical carcinoma

c. Herpes

iii. Leukaemia

d. Retrovirus

iv. Nasopharyngeal carcinoma

  1. a-ii, b-iv, c-i, d-iii
  2. a-i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv 

Q2. The oncogenes which are incorporated into viral genomes usually differ from their normal, cellular counterparts. Given below are some statements regarding it, find the correct one(s)?

P. Their regulatory domains have point mutations that result in loss of regulation.

Q. They may be present in many copies as compared to single copy in cell.

R. They may be expressed from much stronger promoters than the normal cellular.

  1. A. only P
  2. B. P and Q
  3. C. only R
  4. D. P and R

Q3. Cancer generally arises from alteration of critical regulatory genes (protooncogenes) to oncogenes by various tumor viruses. Given below are some virus induced tumors. Match each tumor with their corresponding oncogene-

  1. Simian sarcoma i. sis
  2. Rous sarcoma ii. abl
  3. Abelson sarcoma iii. src
  4. CT10 sarcoma iv. crk

 

  1. ii, b-iii, c-i, d-iv
  2. i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv

Q4. Match the following-

COLUMN A (oncogene)COLUMN B (activation method)
a. abli. point mutation
b. L- mycii. translocation
c. rasNiii. DNA rearrangement
d. retiv. amplification
  1. a-ii, b-iv, c-i, d-iii
  2. a-i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv

Q5. Breast cancer is generally caused by transformation of normal breast cells by oncogenic retroviruses to cancer cells in vitro. This transformation is associated with which of the following reason?

  1. conversion of host DNA to viral RNA
  2. presence of viral particles in host’s membrane
  3. death of host cells due to release of numerous viral particles
  4. viral genome integration into host’s nuclear DNA

Q6. Given below are names of drugs used for treating cancer. Match each drug with their corresponding mode of action-

  1. Sunitinib i. angiogenesis inhibitor
  2. Retinoic acid ii. Monoclonal Ab against oncogene
  3. Herceptin iii. Target oncogene
  4. Imatinib iv. Inhibit PDGF receptor
  1. a-ii, b-iii, c-i, d-iv
  2. a-i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv

 Q7. Erlotinib is a potential drug generally used in the treatment of lung cancer. It works by inhibiting specific receptor. Which of the following is correct about it?

  1. potent inhibitor of EGF receptor
  2. produces antibody against ErbB-2 receptor
  3. potent inhibitor of PDGF receptor
  4. inhibits Bcr/Abl protein tyrosine kinase

Q8. Match the following-

COLUMN A (drug)COLUMN B (oncogene inhibited)
a. Retinoic acidi. abl
b. Herceptinii. PML/RARa
c. Imatinibiii. raf
d. Sorafenibiv. erb-2
  1. a-ii, b-iv, c-i, d-iii
  2. a-i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv

Q9. Given below are some dugs against various types of cancer. Match each drug with their corresponding type of cancer they treat-

  1. Gefitinib i. Lung cancer
  2. Sorafenib ii. Breast cancer
  3. Herceptin iii. Kidney cancer
  4. Erbitux iv. Colorectal cancer
  1. a-ii, b-iii, c-i, d-iv
  2. a-i, b-iii, c- ii, d-iv
  3. a-iii, b-ii, c-i, d-iv
  4. a-ii, b-i, c- iii, d-iv

Q10. Herceptin was the first drug which is primarily a monoclonal antibody against the ErbB-2 oncogene protein and is widely used in treatment of breast cancer. Given below are some statements regarding this drug. Which statement(s) is correct?

  1. produces antibody against a receptor protein tyrosine kinase
  2. helps in elevating ErbB-2 levels
  3. inhibit proliferation of cells in which ErbB-2 is overexpressed
  1. only P
  2. P and Q
  3. only R
  4. P and R

Solutions

Solution-1

COLUMN A (Virus)

COLUMN B (human cancer type)

a. Papilloma

ii. cervical carcinoma

b. Epstein barr

iv. Nasopharyngeal carcinoma

c. Herpes

i. Burkitt’s lymphoma

d. Retrovirus

iii. Leukemia

 

Solution-2

 The oncogenes which are incorporated into viral genomes usually differ from their normal, cellular counterparts. Their regulatory domains have point mutations that may result in loss of protein regulation. They may be expressed from much stronger promoters than the normal cellular promoter. Hence, D is correct option.

Solution-3

  1. Simian sarcoma i. sis
  2. Rous sarcoma iii. src
  3. Abelson sarcoma ii. abl
  4. CT10 sarcoma iv. Crk

Solution-4

COLUMN A (oncogene)

COLUMN B (activation method)

a. abl

ii. translocation

b. L- myc

iv. amplification

c. rasN

i. point mutation

d. ret

iii. DNA rearrangement

Solution-5

Cancer generally arises from the alteration of critical regulatory genes (protooncogenes) to oncogenes by various retroviruses. Breast cancer is generally caused by the transformation of normal breast cells by oncogenic retroviruses to cancer cells in vitro. This transformation is associated with viral genome integration into the host’s nuclear DNA. Hence, D is the correct option.

Solution-6

  1. Sunitinib i. angiogenesis inhibitor
  2. Retinoic acid iii. Target oncogene
  3. Herceptin ii. Monoclonal Ab against oncogene
  4. Imatinib iv. Inhibit PDGF receptor

Solution-7

Erlotinib is a potential drug generally used in the treatment of lung cancer. It works by inhibiting EGF receptor. It has shown good activity against the subset of lung cancer where the EGF receptor is activated by point mutations. Along with this, gefitinib is also a potent drug for treatment of lung cancer with similar mode of action that of erlotinib. Hence, A is the correct option.

Solution-8

COLUMN A (drug)

COLUMN B (oncogene inhibited)

a. Retinoic acid

ii. PML/RARa

b. Herceptin

iv. erb-2

c. Imatinib

i. abl

d. Sorafenib

iii. raf

Solution-9

  1. Gefitinib i. Lung cancer
  2. Sorafenib iii. Kidney cancer
  3. Herceptin ii. Breast cancer
  4. Erbitux iv. Colorectal cancer

Solution- 10

Herceptin was the first drug that is primarily a monoclonal antibody against the ErbB-2 oncogene protein and is used in the treatment of breast cancer. It produces monoclonal antibodies against the extracellular domain of receptor protein tyrosine kinase i.e. ErbB-2. It inhibits the proliferation of cells in which ErbB-2 is overexpressed and lowers the level of ErbB-2. Hence, D is the correct option.

ANSWER KEYS

  1. A
  2. D
  3. B
  4. A
  5. A
  6. B
  7. A
  8. A
  9. B
  10. D

Download Important Questions on CANCER PATHOGENESIS - Download PDF Here

Check Out: 

Hope the above article was helpful for you. Let me know your feedback in the comments section below!!!

More from us:

 

BYJU'S Exam Prep Team

Download the BYJU’S Exam Prep App Now. 

The Most Comprehensive Exam Prep App.

#DreamStriveSucceed

App Link: https://bit.ly/3sxBCsm

Comments

write a comment

Follow us for latest updates